NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2023
Back to search
Official data from USPTO
FASTRAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
09/12/2023
Trademark type
Combined
Nice classes
9, 42, 44
Filing date
06/09/2022
Registration date
09/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2023
Last transaction
09/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Brussels, BE
Examiner
MURRAY, GEORGE
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "FASTRAX" with the letter "X" having two chevrons to the left of the letter, all over a line design.
Holders and representatives
Holders
UCB Biopharma SRL
Representatives
Kumiko Ide WENDEROTH, LIND & PONACK, L.L.P.
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software using Artificial intelligence for use in healthcarefor the coordination and management of patient medical caretracking and monitoring of treatment plans and coordinating patient health informationdatafilesplanscare directivesinstructionscomplianceprogress reports
Class 42
Provision of medical research servicesdeveloping computer software in the field of artificial intelligence software for healthcareon behalf of others; Providing on-line non-downloadable software using Artificial intelligence for use in healthcarein the fields of immunology and rheumatology for analyzing data and improving diagnoses.
Class 44
Medical care and medical analysis services relating to patient diagnosis and treatment
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/24/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/17/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/17/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/17/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/17/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/17/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/23/2023
GNFR
FINAL REFUSAL E-MAILED
03/23/2023
CNFR
FINAL REFUSAL WRITTEN
03/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2022
GNRT
NON-FINAL ACTION E-MAILED
11/18/2022
CNRT
NON-FINAL ACTION WRITTEN
11/18/2022
DOCK
ASSIGNED TO EXAMINER
11/16/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/11/2022
ALIE
ASSIGNED TO LIE
08/11/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/18/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2022
NWAP
NEW APPLICATION ENTERED
06/13/2022
Continuous trademark protection
Get notified about every new filing that threatens FASTRAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.